Loading insider details...
Beta
Latest Form 4 (May 27, 2026): Tax Withholding of 1,630 SGMO shares, $284.11.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 27, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 1,630 | $284.11 |
| Apr 23, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Sale | 69,827 | $17.7K |
| Apr 3, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Grant/Award | 225,000 | n/a |
| Feb 27, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 832 | $393.12 |
| Jan 26, 2026 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 7,721 | $3.1K |
| Nov 26, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 723 | $301.20 |
| Oct 24, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 6,708 | $4.4K |
| Aug 26, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 723 | $423.89 |
| Jul 24, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 6,708 | $3.2K |
| May 28, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Tax Withholding | 723 | $342.20 |